|  | GMA | PSL |
---|---|---|---|
Gender: | Male/Female | 14/10 | 7/10 |
Mean age (range) |  | 33.6(15–78) | 35.4(13–65) |
Extent of UC | Total | 17 | 10 |
 | Left sided | 6 | 5 |
 | Recto-sigmoid | 1 | 2 |
Clinical course | Chronic continuous type | 0 | 1 |
 | Relapsing remitting type | 28 | 14 |
 | First UC episode | 0 | 2 |
Inpatient/Outpatient | Â | 19/5 | 17/0 |
Patients with a history of exposure to PSL | Â | 17 | 13 |
Patients on AZA (50mg/day) | Â | 8 | 8 |